BD is investing $110 million to expand its production of prefillable syringes, helping accelerate biologic and GLP-1 drug delivery.
BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback